DANDELION Identifies Overlooked Asthma Disease Genes
On August 11, 2026, researchers at Columbia University and the University of Chicago reported DANDELION, a computational framework that identified 21 asthma-related genes, most missed by other methods. The University of Chicago reports that CRISPR screens and mouse models validated asthma phenotypes, while two identified genes converged on a previously unstudied asthma pathway involving fatty-acid metabolism and protein palmitoylation.
Researchers at Columbia University Mailman School of Public Health and the University of Chicago have developed DANDELION, a computational framework for prioritizing genes that may directly drive complex disease. In an asthma study published in *Cell*, the method identified 21 genes associated with asthma, most of which had not been found by earlier approaches, according to the University of Chicago.
The team also used CRISPR gene-editing screens and mouse models to test the candidates. The University of Chicago reports that those experiments validated asthma phenotypes and linked two genes to a shared pathway involving fatty-acid metabolism and protein palmitoylation, a process not previously studied in asthma.
Moving beyond association signals
Genome-wide association studies can identify large numbers of DNA variants statistically associated with disease risk, but translating those signals into causal genes remains difficult. Columbia describes DANDELION as a mediation-inspired approach designed to identify genes that sit centrally in disease biology rather than genes connected only indirectly to a risk-associated variant.
The method focuses on trans-gene regulation. As described by the University of Chicago, a variant can alter expression of a nearby gene, which in turn affects other genes through a regulatory network. Conventional association approaches can preferentially surface genes at the network's periphery, while DANDELION is intended to prioritize central disease-driving nodes.
"Current genetic approaches and large-scale studies often identify hundreds of DNA changes linked to disease risk, but it can be difficult to determine which genes are actually causing the disease rather than simply being associated with it," Zhonghua Liu, an assistant professor of biostatistics at Columbia Mailman, said in the university's release. "DANDELION gives researchers a more effective way to pinpoint those genes and the biological pathways they control."
Experimental validation strengthens the result
The study's combination of computational prioritization with functional testing is consequential. Many genomic analyses stop at statistical association or expression-based prioritization, whereas the reported CRISPR and mouse experiments supply independent evidence that the selected genes affect asthma-related phenotypes.
For ML and computational-genomics teams, the work illustrates a broader pattern in disease-gene discovery: methods that model regulatory relationships can produce more actionable hypotheses when paired with perturbation experiments. The practical test is not only whether a method ranks known associations differently, but whether its prioritized genes survive functional validation and help expose coherent biological pathways.
The Columbia release describes the asthma pathway as a potential future therapeutic target. That remains an early-stage research finding rather than a treatment result: the supplied reporting does not describe a clinical intervention, patient trial, or approved therapy based on the pathway. The authors also frame DANDELION as applicable across complex diseases, an assertion that will require disease-specific replication and validation beyond the asthma analysis.
Key Points
- 1DANDELION prioritized 21 asthma-related genes, addressing the gap between genetic association signals and experimentally supported disease drivers.
- 2CRISPR screens and mouse models validated asthma phenotypes, adding functional evidence beyond computational ranking alone.
- 3Comparable network-based genomics workflows can improve target discovery when statistical prioritization is coupled with perturbation-based validation.
Scoring Rationale
The study presents a computational genomics method supported by CRISPR and mouse-model validation, making it more substantive than a purely associative analysis. Its immediate result is limited to asthma and preclinical pathway discovery, but the trans-regulatory prioritization approach is relevant to disease-gene and therapeutic-target research.
Sources
Primary source and supporting public references used for this report.
Practice with real Telecom & ISP data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Telecom & ISP problems
